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Thegrowthhormone (GH)–insulin-likegrowth factor 1
(IGF1) axis mediates postnatal body growth. The GH
receptor has been regarded as the sole receptor
that mediates the Janus kinase 2 (JAK2)/signal trans-
ducers and activators of the transcription 5B
(STAT5B) signal toward IGF1 synthesis. Here, we
report a signaling pathway that regulates postnatal
body growth through EphA4, a member of the Eph
family of receptor tyrosine kinases and a mediator
of the cell-cell contact-mediated signaling. EphA4
forms a complex with the GH receptor, JAK2, and
STAT5B and enhances Igf1 expression predomi-
nantly via the JAK2-dependent pathway, with some
direct effect on STAT5B. Mice with a defective
Epha4 gene have a gene dose-dependent short
stature and low plasma IGF1 levels. Igf1 messenger
RNA (mRNA) in the liver and many other tissues
was also significantly reduced in Epha4-knockout
mice, whereas pituitary Gh mRNA and plasma GH
levels were not. These findings suggest that the local
cell-cell contact-mediated ephrin/EphA4 signal is as
important as the humoral GH signal in IGF1 synthesis
and body size determination.
INTRODUCTION
Growth hormone receptor (GHR) is present as a preformed dimer
in hepatocytes and other cells. Binding of growth hormone (GH)
triggers a conformational change in the extracellular domain that
initiates downstream signaling (Birzniece et al., 2009; Cunning-
ham et al., 1991; Rowlinson et al., 1998). In common with other
cytokine receptors, GHR is devoid of enzymatic activity, and
signal transduction is mediated by Janus kinase 2 (JAK2)
(Pilecka et al., 2007). On binding of GH to the receptor, JAK2 is
catalytically activated by transphosphorylation. Intracellular GH
signaling appears to comprise three main pathways: the signal
transducers and activators of transcription (STAT) pathway, the652 Cell Reports 2, 652–665, September 27, 2012 ª2012 The Authormitogen-activated protein kinase (MAPK) pathway, and the
phosphoinositide 3 (PI-3) kinase pathway (Piwien-Pilipuk et al.,
2002). Although these three pathways are activated by JAK2
transphosphorylation, the JAK-STAT pathway is regarded as
the major effector of GHR signaling and is required for transcrip-
tional regulation of insulin-like growth factor 1 (IGF1) in hepatic
cells as well as locally in tissues (Kofoed et al., 2003). Among
several STAT proteins, STAT5B is directly linked to the transcrip-
tional regulation of IGF1 (Kofoed et al., 2003). Circulating IGF1 is
produced predominantly in hepatocytes (Sjo¨gren et al., 1999;
Yakar et al., 1999) and is present as a ternary complex with
IGF-binding protein 3 (IGFBP3) and acid-labile subunit (IGFALS)
(Domene´ et al., 2004). The ternary complex slows the clearance
of IGF1. Changes in the expression of IGFBP3 and IGFALS play
an important role in modulating the growth-promoting actions of
circulating IGF1, but not of local IGF1. IGFALS is produced by
hepatocytes in a GH-dependent manner. In contrast, IGFBP3
is produced primarily by hepatic endothelial and Kupffer cells
in the liver, although it is widely expressed in many tissues and
themechanism of IGFBP3 transcriptional regulation is not clearly
defined (Binoux, 1997).
The GH-IGF1 axis is a major mediator of postnatal body
growth. Defects in any of the molecules related to the GH-IGF1
axis result in short stature (Walenkamp and Wit, 2006; Woods,
2007). There are currently four known genetic causes of GH
insensitivity (Woods, 2007). Homozygous mutation of the GHR
gene is a cause of short stature (Laron syndrome), which was
originally reported in patients with the classical clinical features
of congenital GH deficiency and an elevated circulating GH level
(Amselem et al., 1989; Godowski et al., 1989; Laron et al., 1966).
Homozygous mutation of STAT5B was subsequently identified
as causing phenotypes similar to severe GHRdeficiency (Kofoed
et al., 2003). Patients with STAT5B mutation have low levels of
IGF1 and IGFBP3 and do not respond to exogenous GH admin-
istration. These genetic defects are associated with normal to
mildly reduced birth weight. In contrast, IGF1 gene deficiency
causes substantial prenatal growth retardation with elevated
levels of GH and normal levels of IGFBP3 and IGFALS (Woods
et al., 1996). Patients with homozygous mutation of the IGFALS
gene exhibit only a mild degree of growth retardation and have
elevated GH secretion and very low circulating levels of IGF1s
and IGFBP3 (Domene´ et al., 2004). Despite this knowledge, there
appear to be many patients with short stature who have no clear
molecular defects in these molecules.
Ephrin receptors (Ephs) belong to a superfamily of receptor
tyrosine kinases classified into two subclasses, A and B, by
their ligand-binding specificity (Kullander and Klein, 2002). The
EphA receptors, with exception of EphA4, bind to ephrin-As,
which are anchored to the cell membrane via a glycosylphos-
phatidylinositol linkage. The EphB receptors bind to ephrin-
Bs, which have a transmembrane domain and a short cyto-
plasmic domain. EphA4 binds not only to all ephrin-As, but
also to ephrin-B2 and ephrin-B3. Ephrin-Eph signaling mediates
a number of functions, including classical repulsive axon guid-
ance, boundary formation, cell migration, and proliferation via
forward signaling from ephrin to Eph and reverse signaling
from Eph to ephrin (Pasquale, 2008). Some signals are stimula-
tory, whereas others are inhibitory. Recent reports suggest that
Eph receptors also regulate angiogenesis in embryonic and
adult tissues (Zhang and Hughes, 2006). We have previously re-
ported their interaction with fibroblast growth factor receptors
(FGFRs) and enhancement of the canonical fibroblast growth
factor signaling pathway (Sawada et al., 2010; Yokote et al.,
2005). However, a complete view of the biologic functions of
Ephs and ephrins has yet to be clarified.
Here, we report functions of EphA4 in JAK2-dependent
and -independent STAT5B activation, leading to enhanced
synthesis of IGF1. Mice defective in the Epha4 gene showed
moderate to severe short stature and low expression of Igf1 in
the liver and many other tissues. Our findings suggest that the
ephrin/EphA4 and GH/GH receptor signal systems function
synergistically in the production of IGF1 in multiple tissues and
contribute to postnatal body and organ growth.
RESULTS
Short Stature in Epha4-Knockout Mice
Short stature is one of the main clinical phenotypes caused
by derangement of the GH-IGF1 axis. Several genetic abnor-
malities have been reported among members of this signal
transduction pathway, including genes for GH, GHR, STAT5B,
and IGF1 (Woods, 2007). We identified short stature in
Epha4+/ and Epha4/ mice (Figure 1A). Prenatal body weight
was similar among the three genotypes: Epha4+/+, Epha4+/,
and Epha4/. However, Epha4+/ and Epha4/ mice showed
significant growth retardation compared with wild-type (WT)
mice after birth. The growth retardation of Epha4+/ mice
was milder than that of Epha4/ mice. This growth deficiency
was clearly present, not only in body size, but also in the skel-
etal system and in organs, such as the liver (Figures 1B and 1C;
Table S1). These findings suggested that EphA4 might be
a determinant of body size after birth.
Generalized Shrinkage of Epiphyseal Growth Plates
in Epha4-Knockout Mice
Longitudinal growth retardation is caused by defective develop-
ment of epiphyseal growth plates. As stated earlier, EphA4 inter-
acts with FGFRs and enhances signaling via the canonical FGFR
signaling pathway (Sawada et al., 2010; Yokote et al., 2005).CelTherefore we examined tibial epiphyseal growth plates to
determine if there was shrinkage or elongation of the prehyper-
trophic chondrocytes, as seen in mice with mutated Fgfr3 (Naski
et al., 1998). Hematoxylin-eosin staining and in situ hybridization
of Col2a1 (collagen 2a1) messenger RNA (mRNA) of epiphyseal
sections revealed severe shrinkage of all layers of growth plates
in Epha4/mice (Figure 1D). This was contrary to the finding ex-
pected from inactivation of FGFR3 signaling, which shows elon-
gation of longitudinal bones (Ornitz, 2001).
Food Intake and Plasma Levels of GH, Thyroxine, and
Corticosterone AreNot Determinants of Small Body Size
in Epha4-Knockout Mice
Malnutrition is amajor cause of growth retardation. To determine
if Epha4-targetedmice had problemswith food intake, we exam-
ined daily food intake in adult mice. Weight-adjusted food intake
in Epha4/ and Epha4+/mice was not reduced compared with
WTmice (Table S1), suggesting that the amount of food intake is
not a determinant of small body size in EphA4-deficient mice.
Body length was also significantly different between Epha4+/+
and Epha4/ mice in both sexes (Table S1). Epha4 knockout
did not significantly alter plasma levels of GH, thyroxine, or corti-
costerone that might influence body size (Figure 1E).
Secretion of GH is reported to be pulsatile, such that the
plasma GH level at a given time point might be misleading with
respect to the state of GH production (MacLeod et al., 1991).
To examine GH expression in the pituitary, we quantified the
amount of GhmRNA by real-time RT-PCR. Quantities were cor-
rected for the amount of 18S ribosomal RNA (rRNA) amplified, as
reported (Iida et al., 2004). TheGhmRNA/18S rRNA values were
not significantly different among the three Epha4 genotypes in
each sex or between sexes (Figure 1F).
Plasma Levels of IGF1, IGFALS, and IGFBP3 Are
Reduced in Epha4-Knockout Mice
Plasma levels of IGF1, IGFALS, and IGFBP3 are important
parameters for the function of the GH-IGF1 axis. Levels of these
proteins were significantly less in Epha4/mice compared with
WT mice in both sexes (Figure 2A). The plasma IGF1 level of
female Epha4/ mice was 49.7% that of WT mice, and that of
male Epha4/ mice was 36.5% that of WT mice. The plasma
IGFALS level of female Epha4/ mice was also reduced to
53.2% that of the control, while that of male Epha4/ mice
was 57.2% that of WT mice (Figure 2B). The IGFBP3 level of
female Epha4/ mice was 34.1% that of WT mice, and that of
male Epha4/ mice was 60.3% that of WT mice (Figure 2C).
The low levels of these three factors in the presence of normal
plasma GH level suggested that the GH-IGF1 axis in the liver is
impaired because of deletion of the Epha4 gene. The smaller
liver size of Epha4/ mice (Figure 1C; Table S1) might imply
functional resistance at the level of GHR or IGF1 receptor
(IGF1R), since EphA4, GHR, and IGF1R are all expressed in
the same cell surface compartment.
Epha4 Knockout Reduces Hepatic mRNA Expression of
Igf1 and Igfals, but Not of Igfbp3, Ghr, or Igf1r
Given that approximately 75% of plasma IGF1 is produced in the
liver in response to GH, we examined the hepatic expression ofl Reports 2, 652–665, September 27, 2012 ª2012 The Authors 653
Figure 1. Body Size of Epha4 Genetically Engineered Mice
(A) Growth curves of Epha4-targetedmice. Bodyweights ofWT (female, n = 14;male, n = 20),Epha4+/ (female, n = 50;male, n = 50) andEpha4/ (female, n = 22;
male, n = 16) mice were measured every week. Data are presented as mean ± SD values. *p < 0.01 compared with WT mice.
(B) Typical body and soft X-ray images of 3-week-old sibling female mice with genotypes of Epha4+/+, Epha4+/, and Epha4/.
(C) Organs of 3-week-old female mice with genotypes of Epha4+/+, Epha4+/, and Epha4/ (upper panels). The abdominal and thoracic organs are viewed from
the back side (lower panels).
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Igf1 mRNA (Figure 2D). Both male and female Epha4/ mice
showed significantly less Igf1 mRNA expression compared
with WT mice. IGFALS, like IGF1, is produced by hepatocytes,
and its transcription depends on the level of GH (Binoux,
1997). In our study, the Igfals mRNA level was also significantly
reduced in Epha4/ mice of both sexes compared with the
WT (Figure 2E). In contrast, expression of Igfbp3mRNA, synthe-
sized primarily by Kupffer cells and sinusoidal endothelial cells in
the liver, is not directly regulated by theGHsignal, and the ternary
complex of IGF1-IGFBP3-IGFALS plays an important role in the
clearance of its components (Binoux, 1997). When hepatic
Igfbp3mRNAwasquantified, the expressionwas similar, regard-
less of the expression of Epha4 in either sex (Figure 2F), suggest-
ing that the low plasma IGFBP3 levels in Epha4/mice are due
to rapid clearance from the circulation caused by the low levels of
plasma IGF1 and IGFALS. These findings support the idea that
the function of GH on hepatocytes mediated by GHR is impaired
inEpha4/mice.Wedemonstrated colocalization of EphA4 and
GHR in HepG2 cells, a hepatoma cell line, using immunocyto-
chemistry followed by detection with a confocal microscope
(Figure S1).
We also examined the expression of liver Ghr and Igf1rmRNA
to obtain the whole picture of the GH-IGF1 axis in Epha4/
mice. The expression of mRNA was unchanged in Epha4/
mice compared with the WT (Figures 2G and 2H). To examine
the significance of Epha4 gene deletion in the liver, we tested
expression of all Epha and Efn members in the liver and found
that multiple Epha members (a1, a2, a3, a4, and a7), Efna
members (a1, a2, a4, and a5), and Efnb members (b1 and b2)
were expressed (Figure 2I). Among the ephrins expressed in
the liver, ephrin-A1, -A2, -A4, -A5, and -B2 are currently regarded
as ligands for EphA4.
Epha4 Knockout Reduces Extrahepatic mRNA
Expression of Igf1, but Not of Ghr or Igf1r
We quantified Igf1, Ghr, and Igf1r mRNA expression levels in
various tissues of WT and Epha4/ mice. Epha4/ mice of
either sex showed significantly lower expression levels of Igf1
mRNA thanWTmice in heart, lung, spleen, stomach, small intes-
tine, colon, skin, and muscle (Figure 3A). However, cerebrum
and kidney showed no significant difference in Igf1 mRNA
expression. In contrast, mRNAs for Ghr and Igf1r were ex-
pressed at similar levels in all of these tissues in WT and
Epha4/ mice (Figures 3B and 3C). In addition, Epha4 was ex-
pressed in all tissues examined in WT mice (Figure 3D).
Interaction of EphA4, GHR, and JAK2
EphA4 belongs to a family of receptor tyrosine kinases located at
the cell surface, where GHRs are also present. There have been
no reports of interaction between these two receptors. There-
fore, we examined their potential interaction in HEK293T cells,(D) Hematoxylin-eosin staining and collagen type 2a1 (Col2a1) mRNA in situ hybri
and Epha4/ mice. Scale bar, 100 mm.
(E) Plasma levels of GH, thyroxine (T4), and corticosterone in Epha4+/+ and Eph
measured as described.
(F) Pituitary Gh mRNA expression. Adult mice 4 months of age or older were use
Data in (E) and (F) are presented as mean ± SD values of six independent sampl
Celinwhich EphA4,GHR, and JAK2were overexpressed (Figure 4A).
The three proteins bound directly to each other, forming a ternary
complex.
We also demonstrated that these molecules, which are ex-
pressed endogenously in fibroblasts, form a complex following
ligand stimulation. Knockdown of Ghr by small hairpin RNA
(shRNA) in fibroblasts (see Figure S2 for Ghr mRNA reduction
by more than 70%) reduced the amount of endogenous EphA4
and JAK2 coimmunoprecipitated with GHR (Figure 4B, left
panels). As shown in the cells from which Epha4 or Jak2 were
genetically deleted, we detected binding of GHR-EphA4 and
GHR-JAK2 (Figure 4B, middle panels). However, the EphA4-
JAK2 binding was not clearly detectable in Ghr/ cells (data
not shown). Interestingly, endogenous STAT5B also bound to
the complex, and EphA4-STAT5B binding was present in the
absence of GHR. Stimulation with ligands completely abolished
the EphA4-STAT5B binding in Ghr/ cells (Figure 4B, right
panels), suggesting the release of STAT5B from activated
EphA4. In addition to these coimmunoprecipitation studies to
detect molecular interactions, we have shown immunocyto-
chemical colocalization of GHR and EphA4 molecules on the
cell surface in the HepG2 hepatoma cell line (Figure S1).
Effect of EphA4 on Signals Downstream of GHR
in Fibroblasts
We cultured fibroblasts from mice in which the Epha4 or Jak2
gene was genetically knocked out and studied receptor binding
and signal transduction in cells with or without retrovirus-based
expression rescue of the respective gene. Notably, fibroblasts
derived from WT mice expressed many of the Epha members
(a1, a2, a3, a4, a5, a7, and a8), Ephb members (b1, b2, b3, b4,
and b6), Efna members (a1, a2, a3, a4, and a5) and Efnb
members (b1, b2, and b3). Knockout or rescue of Epha4 did
not alter mRNA expression levels of other members of the Eph
family or their ligands (Figure 4C).
Fibroblasts from Epha4/ mice showed a decreased
response to GH stimulation in the phosphorylation of tyrosines
in GHR and JAK2, and the response was augmented by rescued
expression of Epha4 (Figure 4D). However, we obtained themost
prominent sustained phosphorylation of GHR/JAK2/STAT5B in
cells preincubated with ephrin-A1 (500 ng/ml) for 45 min before
addition of GH (Figure 4E). Interestingly, ephrin ligand–stimu-
lated enhancement of STAT5B phosphorylation in nonrescued
cells was similar to that in EphA4-rescued cells, suggesting
that EphAs other than EphA4 were also able to augment the
function of ligand-stimulated GHR following strong activation
by ephrin-A1. Binding of EphA4 to the GHR/JAK2 complex
was clearly demonstrated by coimmunoprecipitation studies
with anti-GHR or anti-JAK2 antibody (Figure 4E). The binding
appeared to be strengthened by activation of EphA4 with
ephrin-A1. In addition, ephrin-A1 stimulation alone induced rapiddization of epiphyseal growth plates of tibiae from 3-week-old female Epha4+/+
a4/ mice. Blood was drawn early in the morning, and hormone levels were
d. Pituitary Gh mRNA relative to 18S rRNA was measured as described.
es. See also Table S1 for additional information.
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Figure 2. Circulating Levels of IGF1,
IGFALS, and IGFBP3 and Hepatic mRNA
Expression of Igf1, Igfals, Igfbp3, Ghr,
Igf1r, Ephas, and Efns
(A–H) Plasma values of IGF1 (A), IGFALS (B), and
IGFBP3 (C) in Epha4-targeted mice. Plasma con-
centrations of IGF1 and IGFBP3 were measured
using ELISA kits. Relative plasma IGFALS levels
were determined by immunoblotting of plasma
samples (bottom panel of B), followed by a densi-
tometric analysis (B, top panel). Expression of liver
Igf1 mRNA (D), Igfals mRNA (E), Igfbp3 mRNA (F),
Ghr mRNA (G), and Igf1r mRNA (H) in the Epha4-
targeted mice. Quantitative real-time RT-PCR
was carried out as described, and relative Igf1
mRNA abundance was calculated according to
the comparative Ct (delta delta Ct) method, using
Gapdh mRNA as a control. Data in (A)–(H) are
presented as mean ± SD values of eight inde-
pendent samples. *p < 0.01 compared with
Epha4+/+ mice of the same sex.
(I) Expression of mRNA for the families of Epha,
Efna, and Efnb in the liver. RT-PCRwas performed
as described. G, Gapdh mRNA.
See also Figure S1.phosphorylation of GHR-bound tyrosine-containing molecules,
including EphA4 and JAK2, in EphA4-rescued cells, followed by
weak STAT5B phosphorylation at a later time point (120 min),
whereas STAT5B phosphorylation was not present in non-
rescued cells (Figure 4F).656 Cell Reports 2, 652–665, September 27, 2012 ª2012 The AuthorsTo further clarify the direct interaction
between EphA4 and GHR, we carried
out binding studies in Jak2/ fibroblasts
(Wagner et al., 2004) (Figure 4G). Results
showed that EphA4 bound to GHR in the
absence of JAK2, supporting the results
of Figure 4A. In addition, binding of
EphA4 toGHRwas enhanced by preincu-
bation of Jak2/ fibroblasts with ephrin-
A1 or GH.
Effect of EphA4 Expression on Igf1
mRNA Expression in Fibroblasts
We examined how rescued expression of
EphA4 affected expression of Igf1mRNA
in Epha4/ fibroblasts (Figure 4H). Fibro-
blasts with rescued EphA4 expression
showed enhanced basal Igf1 mRNA
expression and augmented response to
GH or ephrin-A1 compared with control
fibroblasts transduced with vector alone.
These findings suggested that EphA4
was not only an important molecular
component of the GH signaling pathway,
but was also related to GH-independent
Igf1 mRNA expression (basal expression
level of Igf1 mRNA).
We further examined whether the effect of EphA4 was medi-
ated by JAK2 in Jak2/ fibroblasts with or without rescued
Jak2, which express endogenous EphA4 or overexpress it. In
cells transduced with retrovirus vector carrying Jak2 and/or
EphA4 expression cassettes, these genes were overexpressed
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and the products were phosphorylated slightly, suggesting
a primed active state of these receptors (Figure 5A). In the
absence of stimulation with ephrin-A1, STAT5B was phosphory-
lated only in Jak2-rescued cells, with a large enhancement by
EphA4 overexpression. Corresponding to these results, the
Igf1 mRNA expression level increased when Jak2 was rescued
and the increase became significant when EphA4 was overex-
pressed (Figure 5B).
In these cells, ephrin-A1 induced STAT5B phosphorylation in
the presence of JAK2 expression, with a peak at approximately
60 min to 120 min of exposure (Figure 5C). Surprisingly, STAT5B
was also phosphorylated in Jak2/ fibroblasts, and its phos-
phorylation was enhanced by overexpressed EphA4, suggest-
ing the presence of a JAK2-independent STAT5B activation
pathway mediated by EphA4. As shown at the bottom of Fig-
ure 5C, STAT5B was coimmunoprecipitated with EphA4 only
before stimulation with ephrin-A1 (at 0 min points), even in the
absence of JAK2, suggesting a direct complex formation of non-
phosphorylated STAT5B with EphA4 and a quick release of
phosphorylated STAT5B from the complex. These findings are
in agreement with those shown in Figure 4B.
In accordance with these results, in the presence of endog-
enous EphA4 expression, Igf1 mRNA expression increased
greatly in response to ephrin-A1 when Jak2 was rescued (Fig-
ure 5D), implying ephrin-A1-mediated augmentation of Igf1
transcription in the presence of primed JAK2 activation. To
examine whether the effect of ephrin/Eph signal was mediated
totally by JAK2, we also tested the effect of ephrin-A1 on Igf1
expression in Jak2/ cells with varying expression levels of
EphA4 (Figure 5E). The Igf1 mRNA expression increased signif-
icantly beyond the unstimulated basal level, although the
response was almost one-tenth that of the Jak2-rescued cells.
In the presence of rescued Jak2 expression, EphA4 overex-
pression alone increased the basal Igf1 mRNA expression level
and ephrin-A1 treatment further increased this expression (Fig-
ure 5F). Taken together, in an ephrin ligand-activated state,
90% of the effect of EphA4 was mediated by JAK2 and 10%
appeared to be JAK2-independent in fibroblasts.
Effect of EphA4 on IGF1 Signal Transduction
We also examined signals downstream of IGF1R, insulin
receptor substrate 1 (IRS1), MAPK, and AKT in response to
varying doses of IGF1 (Figures 6A and 6B). In the absence of
preincubation with ephrin-A1, IGF1 induced phosphorylation of
IRS1, AKT, and MAPK to a similar level regardless of EphA4
expression (Figure 6B). However, when preincubated with
ephrin-A1, IGF1-induced phosphorylation of IRS1, and AKT,
a downstream signaling molecule of PI-3 kinase was augmented
in Epha4/ cells compared with that in the EphA4-rescued cells
(Figures 6A and 6C). On the contrary, activity of another signalingFigure 3. Extrahepatic Expression of mRNAs for Igf1, Ghr, Igf1r, and E
(A–C) Expression of Igf1mRNA (A), GhrmRNA (B), and Igf1rmRNA (C) in various t
(male), kidney (male), spleen (female), stomach (female), small intestine (female), c
PCR was carried out as described. Data in (A)–(C) are presented as mean ± SD v
sexes. *p < 0.01 compared with Epha4+/+ mice.
(D) Expression of Epha4 in various tissues. RT-PCR was performed as described
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preincubation with ephrin-A1. These findings suggested that
the PI-3 kinase pathway downstream of IGF1 signaling was
a target signal transduction pathway affected by expression
and activation of EphA4.
Effect of Treatment with GH and IGF1
To determine whether IGF1 or GH treatment can recover
Epha4/ mice from growth retardation, we subcutaneously in-
jected recombinant human IGF1 (5 mg/kg body weight (BW)/
day) or porcine GH (10 mg/kgBW/day) into female mice between
6 and 10 weeks of age (Figures 7A–7C). The mice treated with
IGF1 gained significant weight compared with control mice in-
jected with saline alone and attained the same body size as WT
mice after 5 weeks of injections. However, the mice treated
with GH did not significantly increase their body weight
compared with the control mice. Consistent with this finding,
plasma IGF1 level did not change in response to GH treatment
(Figure 7D).
DISCUSSION
We have presented evidence that EphA4 is an important compo-
nent of the GHR signaling pathway, leading to IGF1 synthesis
without affecting the expression of GHR or IGF1R. It has been re-
ported that JAK2/STAT5B mediates the expression of IGF1
mRNA after GH-mediated activation of GHR (Piwien-Pilipuk
et al., 2002). In the present study, we demonstrated that interac-
tion of EphA4 with GHR, JAK2, and STAT5B resulted in
enhanced JAK2/STAT5B activation in response to stimulation
with ephrin and GH, leading to enhancement of JAK2/STAT5B-
dependent Igf1 mRNA expression. For this signal activation in
fibroblasts, GH plays a major role. In addition, another signal
leading to increased Igf1 mRNA expression can be induced
without JAK2 (JAK2 independent) and is dependent on activa-
tion of EphA4 by its ligand, ephrin. STAT5B directly binds to
EphA4 and mediates this JAK2-independent Igf1 expression.
The significance of this EphA4/STAT5B signaling pathway
remains to be elucidated, given that the extent of Igf1 mRNA
production by this pathway is weak in fibroblasts. Because
endogenous ephrin is not circulating, it should function in a
cell-cell contact-mediated fashion. We have preliminary binding
data, obtained by using deletion mutants of EphA4, which show
that GHR binds to the extracellular domain of EphA4 and that
EphA4 contains the binding site for STAT5B (D.A., T.S., and
K.S., unpublished data). There is one report that the JAK2 and
STAT proteins are downstream targets of EphA4 signaling in
the regulation of muscle acetylcholinesterase expression
(Lai et al., 2004). This might be explained by our finding that
EphA4, GHR, and JAK2 form a complex. We have also shownpha4
issues. Tissue RNA was extracted from cerebrum (female), heart (female), lung
olon (female), skin (male), and soleus muscle (male), and quantitative real-time
alues of eight independent samples from the same sex and are similar for both
.
s
Figure 4. Interaction of EphA4, GHR, and JAK2 and Signaling via the Complex
(A) Interaction of EphA4, GHR, and JAK2 in HEK293T cells. EphA4-3Flag, GHR-6myc, and Jak2-HA in pcDNA3.1 vector were expressed in HEK293T cells, and
their interaction was studied via immunoprecipitation (IP) and/or immunoblotting (IB).
(B) Interaction of endogenous EphA4, GHR, and JAK2 inmouse fibroblasts. Fibroblasts derived from Epha4/, Jak2/,Ghr/, andWTmicewere preincubated
with serum-free medium overnight (no ligands) and incubated with ephrin-A1 for 45min followed by treatment with GH for 30min (pre-A1 + GH). Cell lysates were
used for IP and/or IB studies with the indicated antibodies. The WT fibroblasts were also infected with a lentivirus that expressed Ghr shRNAs or with a control
shRNA (C shRNA).
(C) RT-PCR of Epha (upper panel), Ephb, Efna, and Efnb (bottom panel) families of mRNAs. Except for Epha4, all Eph and Efn expression levels were comparable
in Epha4/ (right lanes) and retrovirally Epha4-rescued (left lanes) mouse fibroblasts, although only Epha family mRNAs are shown for these two origins of
fibroblasts (upper panel). The same amount of RNA from each sample was used for RT.
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that EphA4 does not alter IGF1/IGF1R-mediated MAPK activity,
but merely desensitizes the response of the PI-3 kinase pathway
upon activation with ephrin, making it difficult to attribute the
growth retardation in Epha4-knockout mice to the derangement
of IGF1R-EphA4 interaction.We speculate that the lack or loss of
EphA4 signaling, possibly due to mutations or polymorphisms of
EphA4, causes deficient IGF1 synthesis via suppression of both
the GHR/EphA4/JAK2/STAT5B and the EphA4/STAT5B path-
ways, leading to growth retardation.
The present findings that Epha4-knockout mice exhibited
short stature with low circulating levels of IGF1, IGFALS, and
IGFBP3 and low Igf1 mRNA expression in many tissues are
consistent with the idea that IGF1 of both endocrine and local
origin plays an important role in body growth. In a study in
mice lacking Ghr and/or Igf1 (Lupu et al., 2001) and another
study in mice carrying liver-specific expression of Igf1 via
cognate Igf1 promoters in an Igf1 null background (Stratikopou-
los et al., 2008), their results showed that endocrine IGF1 indeed
significantly contributes (30%) to adult body size with a 39%
contribution of local tissue IGF1. In Epha4-knockout mice, levels
of plasma IGF1, IGFALS, and IGFBP3 were one-third to one-half
those of WT mice. These levels are not as low as those in the
conditional hepatic Igf1-knockout mice (Sjo¨gren et al., 1999;
Yakar et al., 1999) that show normal body size. Nevertheless,
Epha4-knockout mice exhibited short stature. This discrepancy
may be explained by congenital deletion of EphA4 from both
the liver and local tissues in Epha4-knockout mice and gradual
postnatal deletion of Igf1 expression from the liver in the hepatic
Igf1-knockout mice. Furthermore, our results, which show that
IGF1 but not GH replacement treatment is effective for restoring
body growth, are compatible with the derangement of GHR
signal transduction in Epha4-knockout mice. This finding
supports the notion that endocrine IGF1 plays an important
role in normal body growth.
The Epha4-knockout mice showed deranged expression of
local Igf1 in many tissues. This local Igf1 expression does not
completely depend on GH in all tissues (Lupu et al., 2001).
Expression of Igf1 in tissues, such as the skeletal system, brain,
lung, heart, spleen, testis, and uterus, appears to be GH-inde-
pendent, and the expression depends in part on GH in skeletal
muscle, adipose tissue, ovary, and kidney, in contrast to the
complete dependence on GH in the liver. In the present study,
Epha4-knockout mice showed a significantly decreased amount(D) Effect of GH on the GHR/JAK2 signal. Epha4/ (retrovirus vector) and Epha4-r
periods shown at the top. Samples were immunoprecipitated and detected by im
(E) (Top four panels) Effect of activation of Eph receptors and/or GHR by ligand
Epha4-rescued fibroblasts were incubated with GH for the time periods shown at
Sampleswere immunoprecipitated and detected by immunoblotting with the indic
Study conditions were identical in the four groups of samples detected by the sa
(F) Effect of ephrin-A1 on GHR/JAK2/STAT5B phosphorylation. Epha4/ and E
shown at the top. Samples were detected by immunoblotting with or without imm
(G) Interaction of endogenous GHR with EphA4 in the absence of JAK2 expressio
the time periods shown at the top with or without pre-ephrin-A1treatment for 4
following immunoprecipitation using the indicated antibodies.
(H) Effect of ligand stimulation on Igf1mRNA expression in Epha4/ (white bars) a
and/or ephrin-A1 for 36 hr. Data are presented as mean ± SD values of six indepe
cells.
See also Figures S1 and S2.
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lung, heart, and spleen. These tissues likely depend heavily on
EphA4 for Igf1 expression. However, cerebrum and kidney
showed no significant decrease in Igf1 mRNA, suggesting that
EphAs other than EphA4 might compensate for the function of
EphA4 in these tissues. Alternatively, the function of EphA4
might be less important than other signals for IGF1 expression
in some tissues, including brain and kidney.
The plasma GH level was unaltered in Epha4-knockout mice.
The reason for the unchanged plasma GH level, which could
be elevated in the presence of a low plasma IGF1 level, remains
to be clarified. Since neitherGhmRNA expression in the pituitary
nor Igf1r mRNA expression in other tissues was altered, the
plasma levels of IGF1 (35%–50% of WT mice) might not be
low enough to induce GH synthesis or secretion. The apparent
low levels of plasma IGF1 might also be exaggerated by low
levels of IGFBP3 and IGFALS in Epha4-knockout mice. IGFBP3
and IGFALS are important counterparts for ternary complex
formation with IGF1 in the circulation and determinants of circu-
lating IGF1 concentration (Binoux, 1997). In mice with a liver-
specific Igf1 gene deletion or a double deletion of liver Igf1 and
Igfals genes, GH level is elevated due to loss of feedback
suppression by low levels of serum IGF1 (Sjo¨gren et al., 1999;
Yakar et al., 1999, 2006). However, micewith single genetic dele-
tion of Igfals or Igfbp3 do not show such increases in serum GH
level, despite a significant reduction in serum IGF1 level (Yakar
et al., 2006, 2009). These findings suggest that the formation of
a ternary complex of IGF1 with IGFBP3 and IGFALS does not
constitute the functional fraction of IGF1, which is not clearly
defined at this moment in the feedback mechanism of GH
synthesis or secretion (Elis et al., 2011). In the case of Epha4-
knockout mice in which liver Igfbp3 expression is kept normal
and expression of both Igf1 and Igfals is low, the IGF1 fraction
responsible for GH suppression might not be reduced, despite
the reduced total plasma IGF1 level. Another possibility is that
this discrepancy might be caused by derangement of
the feedback signaling mechanism from IGF1 to GH, owing
to absence of EphA4 in the pituitary and/or hypothalamus (Gius-
tina and Veldhuis, 1998). The feedback mechanism in
somatotroph cells appears to be mediated by PI-3 kinase, not
by MAPK or S6 kinase (Niiori-Onishi et al., 1999). In our study,
deletion of Epha4 in fibroblasts clearly sensitized activation of
AKT, a downstream signaling molecule of PI-3 kinase, afterescued (retrovirus EphA4-Flag) fibroblasts were incubated with GH for the time
munoblotting with the indicated antibodies. pY, phosphorylated tyrosine.
s on the tyrosine phosphorylation of GHR/JAK2 and STAT5B. Epha4/ and
the top with or without a 45 min preincubation with ephrin-A1 (pre-ephrin-A1).
ated antibodies. (Bottom four panels) Interaction of EphA4with GHR and JAK2.
me antibodies.
pha4-rescued fibroblasts were incubated with ephrin-A1 for the time periods
unoprecipitation using the indicated antibodies.
n. EphA4-Flag-overexpressing Jak2/ fibroblasts were incubated with GH for
5 min. Interaction of GHR with EphA4-Flag was detected by immunoblotting
nd Epha4-rescued (black bars) fibroblasts. Fibroblasts were incubated with GH
ndent experiments. *p < 0.05 and **p < 0.01 compared with the vehicle-treated
s
Figure 5. Effect of EphA4 or Jak2 Expression and Ephrin-A1 Stimulation on Igf1 mRNA Expression in Jak2/ Fibroblasts
(A) Basal expression of pSTAT5B, STAT5B, pEphA4, EphA4, pJAK2, and JAK2 in Jak2/ and Jak2-rescued fibroblasts with or without EphA4 overexpression.
Cell lysates were immunoprecipitated and immunoblotted with the indicated antibodies.
(B) Effect of EphA4 overexpression (gray bars) on Igf1 mRNA expression in Jak2/ and Jak2-rescued fibroblasts. Cells expressing endogenous Epha4 are
indicated by white bars.
(C) Effect of ephrin-A1 on the phosphorylation of JAK2 and STAT5B and on the binding of STAT5B to the complex involving EphA4 in Jak2/ and Jak2-rescued
fibroblasts with or without EphA4 overexpression. Cells were exposed to ephrin-A1 for the time periods shown. Cell lysates were subjected to immunopre-
cipitation and immunoblotting with the indicated antibodies. Endo, endogenous; Overexp, overexpressed.
(D) Effect of ephrin-A1 stimulation (black bars) and/or Jak2 expression rescue on Igf1 mRNA expression in Jak2/ fibroblasts expressing endogenous Epha4.
Cells not stimulated with ephrin-A1 are indicated by white bars hereafter.
(E) Effect of ephrin-A1 stimulation (black bars) and/or EphA4 overexpression on Igf1 mRNA expression in Jak2/ fibroblasts.
(F) Effect of ephrin-A1 stimulation and/or EphA4 overexpression on Igf1 mRNA expression in Jak2-rescued fibroblasts.
Data in (B), (D), (E), and (F) are presented as mean ± SD values of six independent experiments. Statistical analysis was carried out via two-way ANOVA followed
by the Neuman-Keuls multiple comparison test.IGF1 stimulation in the presence of ephrin-A1 pretreatment. This
might explain, at least partially, the discrepancy shown here if the
same mechanism is applicable to somatotroph cells in the pitu-
itary gland.
In conclusion, we have demonstrated that EphA4 plays an
important role in JAK2-dependent and -independent signal
transduction pathways, leading to increased IGF1 production.CelThe absence of EphA4 expression decreased the amount of
IGF1 in the circulation and locally in tissues, which contributed
to the short stature. Our results propose a model in which
a long-range GH/GHR-mediated humoral signal is modulated
by a short-range, cell-cell contact-mediated ephrin/Eph signal
for determining body and organ size. This finding implies the
presence of a fine-tuning mechanism for appropriate body andl Reports 2, 652–665, September 27, 2012 ª2012 The Authors 661
Figure 6. IGF1 Signaling in the Presence or
Absence of EphA4 Expression
Epha4/ and EphA4-rescued fibroblasts were
incubated for 30 min with IGF1 in the presence (A)
or absence (B) of preincubation with ephrin-A1 for
45 min. Activation of IRS1, AKT, and MAPK were
examined with antibodies that detect active
phosphorylated molecules (pIRS1, pAKT, and
pMAPK) and total amount of these proteins (IRS1,
AKT, and MAPK).
(C) Effect of ephrin-A1 preincubation (PreA1) on
AKT activation. AKT activation after a 30 min IGF1
stimulation was quantified in five different experi-
ments (bottom blotting data), and values were
expressed as the ratio of pAKT/AKT (top graph).
ns, not significantly different.organ size that is coordinated by both humoral factors and local
cell-cell interactions through a shared signaling pathway.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were performed in compliance with the guidelines of
the institutional animal committee and the Japanese government.
Epha4-targeted mice were originally obtained from the laboratory of
Dr. P. Charnay (Helmbacher et al., 2000). In the current study, data were
obtained from the mice of a mixed background that were maintained in
a closed colony, as described in the Extended Experimental Procedures.
Littermate controls were used for histological and morphological studies,
and for other studies, mice of different genotypes in the closed colony were
used for comparison.
Mice between 6 and 10weekswere used for treatment with human IGF1 and
porcine GH. IGF1 (5 mg/kgBW/day) or GH (10 mg/kgBW/day) dissolved in
salinewas subcutaneously injected intomice once a day at 9 a.m. Bodyweight
was measured once a week for 5 weeks.
Measurements of Body Weight, Body Length, and Food Intake
Starting frombirth, bodyweights of allmiceweremeasuredweekly for 28weeks
with a calibrated electronic balance (SP601 Scout Pro Balance; Ohaus Corp.).662 Cell Reports 2, 652–665, September 27, 2012 ª2012 The AuthorsBody length (nose-to-anus distance) was
measured at 16 weeks or older with an electronic
digital caliper (Traceable Digital Caliper; Fisher
Scientific). Food intake was measured daily as the
weight difference of dried food in the cage. Scat-
tered food was carefully collected for weighing.
Assays of Plasma GH, Thyroxine, and
Corticosterone
Mice were killed by decapitation in the morning,
and blood was collected in a tube with a drop of
heparin for separation of plasma by centrifugation.
Growth hormone was measured with a rat/mouse
growth hormone 96-well plate assay kit (Millipore;
catalog #EZRMGH-45K), thyroxine was measured
by SRL (Tokyo, Japan) with the use of a Cobas T4
assay system, and corticosterone was measured
by SRL according to a reported method (Nabors
et al., 1974).
Assays of Plasma IGF1 and IGFBP3
Plasma levels of IGF1 and IGFBP3 were measured
with amouse IGF1 HS Elisa Kit (ImmunodiagnosticSystems Ltd.) and a Duoset Elisa Development Kit for mouse IGFBP3 (R&D
Systems), respectively, according to manufacturers’ instructions.
Cells
Mouse fibroblasts with genotypes of WT, Epha4/, and Ghr/ (Zhou et al.,
1997) were derived from E14.5 mice using a standard protocol,
and the genotype was determined subsequently. Cells from each embryo
were maintained individually in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% fetal calf serum. Fibroblasts from Jak2/
mice were a gift from Drs. Wagner and Lin, Nebraska Medical Center.
Before incubation with human GH or clustered ephrin-A1, cells were plated
onto 6-cm plates at 5 3 105 cells per plate, and once at 70% to 80% con-
fluency, they were preincubated overnight with serum-free minimum
essential medium containing 0.5% bovine serum albumin. For quantifica-
tion of mRNA by real-time RT-PCR, incubation with ligands was usually
for 36 hr. For knockdown of Ghr mRNA, fibroblasts were infected with a
lentivirus expressing shRNAs (Santa Cruz, catalog #sc-40016-v) for Ghr
mRNA at a multiplicity of infection (MOI) of 10. A control shRNA lentivirus
(Santa Cruz, catalog #sc-108080) was also used for control cells with the
same MOI.
HEK293T cells were cultured and used for transfection as described
(Sawada et al., 2010). HepG2 cells were provided by the RIKEN BRC through
the National Bio-Resource Project of the MEXT, Japan and cultured in DMEM
supplemented with 10% fetal calf serum.
Figure 7. Effect of GH and IGF1 on Body Growth
Mice were treated with IGF1 (5 mg/kgBW) and GH (10 mg/kgBW), and their body weight (A and B), body weight gain (C), and plasma IGF1 levels (D) were
measured. Reagent in saline or saline alone was subcutaneously injected into female Epha4/ or Epha4+/+mice between 6 and 10 weeks of age once a day, and
body weight was compared before and after 5 weeks of treatment. Plasma IGF1 levels were also measured after 5 weeks of treatment and represent only mouse
IGF1. Data in each group are presented as mean ± SD values of six independent samples. Data were analyzed statistically by one-way ANOVA followed by the
Neuman-Keuls multiple comparison test. *p < 0.05.Construction of Eukaryotic Expression Vectors and Retrovirus
Expression Vectors
For transient eukaryotic expression in HEK293T cells, complementary DNAs
(cDNAs) for human EphA4, mouse Jak2, and rabbit GHR were incorporated
into pcDNA3.1 vector with tags (3Flag, HA, and 6myc, respectively). For retro-
viral expression, cDNA for WT Epha4 or Jak2 was ligated into the pMXs-IG
vector (Kitamura et al., 2003) and incorporated into retrovirus as reported
(Yokote et al., 2005) using cotransfection of the pMXs-IG–based constructs
with pCAGVSV-G, which encodes vesicular stomatitis virus surface protein
under the control of the chicken b-actin promoter. Transduction of cells with
retrovirus was generally performed with a MOI of 5.
Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting were performed as reported (Yokote
et al., 2005; Zhang et al., 2007) according to the standard procedures
described in detail in the Extended Experimental Procedures.
RT-PCR
RNA extraction and RT-PCR were carried out according to the standard
procedures described in detail in the Extended Experimental Procedures.
See also Table S2 for the primers used.
Quantitative Real-Time RT-PCR Analysis
The analysis was carried out according to the standard proce-
dures, as described in the Extended Experimental Procedures. Pituitary Gh
mRNA was quantified as reported (Iida et al., 2004). To assess expres-Celsion levels of Igf1, Igfals, Igfbp3, Ghr, and Igf1r mRNA in tissues and fibro-
blasts, we used the comparative Ct (delta delta Ct) method to nor-
malize target gene mRNA to Gapdh mRNA, as reported (Kohsaka et al.,
2007).
In Situ Hybridization
In situ hybridization was carried out according to the standard procedure,
as described in the Extended Experimental Procedures. Antisense and
sense complementary RNA probes for collagen type II (Col2a1; 138–
551 of NM031163) were used to identify differentiated chondrocytes.
Probes were labeled with digoxigenin (DIG) by a DIG RNA-labeling
method (Roche Diagnostics; catalog #1175025) according to the manufac-
turer’s instructions. Samples were examined with a Keyence BZ-9000
microscope.
Statistical Analysis
Comparison between two values was performed by Student’s t test. Multiple
values were compared by one-way or two-way analysis of variance (ANOVA),
depending on the number of variables to be tested, followed by Newman-
Keuls multiple comparison test.
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